This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Arsanis Biosciences Gmbh, Janssen Pharmaceuticals, Inc., Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 4 
2 out of 161 
1 out of 1,334 
Years Active: 2017-2025
Title: Irina Mirkina: Innovator in Medical Antibody Development
Introduction
Irina Mirkina is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of medical science, particularly in the development of antibodies targeting multi-drug resistant strains of bacteria. With a total of 7 patents to her name, Mirkina's work is paving the way for advancements in diagnostics and treatment.
Latest Patents
One of her latest patents is titled MDRimmunogen. This invention relates to an isolated antibody that specifically binds to the O25b antigen of multi-drug resistant (MDR) strains. The patent outlines its medical and diagnostic uses, as well as the method of producing the antibody. This includes an isolated nucleotide sequence, plasmids, and host cells utilized in the production process. Additionally, the patent describes an isolated epitope recognized by the specific antibody, further enhancing its potential applications in medicine.
Career Highlights
Throughout her career, Irina Mirkina has worked with notable companies in the pharmaceutical and biotechnology sectors. She has been associated with Arsanis Biosciences GmbH and Janssen Pharmaceuticals, Inc., where she has contributed her expertise in antibody development and research.
Collaborations
Irina has collaborated with several professionals in her field, including Eszter Nagy and Adriana Badarau. These partnerships have allowed her to expand her research and innovate further in the realm of medical science.
Conclusion
Irina Mirkina's contributions to the field of medical antibodies are noteworthy and impactful. Her innovative work continues to address critical challenges in treating multi-drug resistant infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile